Today: 19 May 2026
Browse Category

NASDAQ:CGC 7 November 2025 - 24 December 2025

Canopy Growth (CGC) Stock on Dec. 24, 2025: Schedule III Executive Order, MTL Cannabis Deal, and the Latest Forecasts

Canopy Growth (CGC) Stock on Dec. 24, 2025: Schedule III Executive Order, MTL Cannabis Deal, and the Latest Forecasts

Canopy Growth shares closed at $1.40 on Dec. 23, up 6.06%, after heavy trading and sharp swings throughout December. The volatility followed a Dec. 18 White House executive order directing marijuana rescheduling from Schedule I to III. Trading volume spiked to over 216 million shares on Dec. 18, with implied volatility near 143%. U.S. exchanges operated a shortened session on Dec. 24.
24 December 2025
····
Tilray Stock Surges as Trump Schedule III Buzz Collides With New Vape Launch and Reverse Split Fallout

Tilray Stock Surges as Trump Schedule III Buzz Collides With New Vape Launch and Reverse Split Fallout

Tilray Brands shares surged December 15 as global cannabis stocks rallied on reports that Donald Trump may push to reclassify marijuana as a Schedule III drug. The move, which would ease federal restrictions but stop short of legalization, fueled investor optimism over potential tax and banking benefits for the industry. Tilray also completed a 1-for-10 reverse stock split and reported momentum in its Canadian portfolio.
15 December 2025
····
Canopy Growth Corporation Stock (CGC) Surges on Trump Marijuana Rescheduling Reports: Latest News, Forecasts, and What Comes Next (Dec. 15, 2025)

Canopy Growth Corporation Stock (CGC) Surges on Trump Marijuana Rescheduling Reports: Latest News, Forecasts, and What Comes Next (Dec. 15, 2025)

Canopy Growth shares surged as much as 17.9% in early European trading Monday, extending Friday’s 54% jump, after reports that President Trump may reclassify marijuana as a Schedule III drug. Trading volume spiked, with speculation focused on potential U.S. federal reform and its impact on cannabis industry taxes. No final decision has been confirmed by the White House.
15 December 2025
··
Top Stock Gainers Today (Dec. 12, 2025, 12:30 p.m. ET): cbdMD, Canopy Growth, Tilray Lead a Cannabis-Fueled Rally

Top Stock Gainers Today (Dec. 12, 2025, 12:30 p.m. ET): cbdMD, Canopy Growth, Tilray Lead a Cannabis-Fueled Rally

cbdMD (YCBD) surged 126.6% to $1.43 by 12:30 p.m. ET, leading US stock gainers amid reports President Trump may ease federal marijuana restrictions. Major indexes fell, with the S&P 500 down 1.05% and Nasdaq 100 off 1.8%. Small-cap and cannabis stocks outperformed on policy speculation and company news.
12 December 2025
····
Canopy Growth Corporation Stock (CGC) Jumps on Trump Marijuana Rescheduling Report — News, Forecasts, and What Investors Are Watching (Dec. 12, 2025)

Canopy Growth Corporation Stock (CGC) Jumps on Trump Marijuana Rescheduling Report — News, Forecasts, and What Investors Are Watching (Dec. 12, 2025)

Canopy Growth shares jumped about 21% in premarket trading Friday after reports said President Trump is expected to direct federal agencies to reclassify marijuana as a Schedule III drug. The move, first reported by the Washington Post and cited by Reuters, triggered a surge across US-listed cannabis stocks. No final decision has been made, according to a White House official.
12 December 2025
····
Canopy Growth (CGC) Stock Outlook December 2025: Debt Prepayment, Lawsuit Pressure and a High‑Risk Turnaround

Canopy Growth (CGC) Stock Outlook December 2025: Debt Prepayment, Lawsuit Pressure and a High‑Risk Turnaround

Canopy Growth shares closed at $1.15 on December 5, down 4.96%, but remain up about 13–14% over the last 10 sessions. Q2 FY2026 net revenue rose 6% to C$66.7 million, with gross margin improving to 33%. Net loss narrowed sharply to C$1.6 million from C$131.6 million a year earlier. The company ended the quarter with C$298 million in cash, exceeding its total debt.
6 December 2025
··
Canopy Growth (CGC) Lifts ‘Going Concern’ Doubts as Cash Tops Debt; Q2 FY2026 Shows 30% Canada Adult‑Use Growth

Canopy Growth (CGC) Lifts ‘Going Concern’ Doubts as Cash Tops Debt; Q2 FY2026 Shows 30% Canada Adult‑Use Growth

Canopy Growth reported Q2 FY2026 net revenue of C$66.7 million, up 6% year over year, and ended the quarter with C$298 million in cash, exceeding total debt by C$70 million. The company lifted its going-concern warning. Shares rose as much as 19% premarket before turning volatile. Operating loss narrowed to C$17 million, down 63% from a year ago.
7 November 2025
·

Stock Market Today

  • NIO Stock Rebound Seen Overvalued by 24.8% Despite Recent Gains
    May 19, 2026, 4:40 PM EDT. NIO's share price rebounded to around US$5.88, yet a Discounted Cash Flow (DCF) analysis indicates it is overvalued by approximately 24.8%, falling short of its intrinsic value estimated at US$4.71 per share. The electric vehicle maker's stock is down 3.1% last week and 13.9% over the past month, but still up 14.4% year-to-date and 45.5% over the past year. NIO scores only 2 out of 6 on valuation checks, reflecting investor concerns around capital needs, production plans, and competitive pressures. The company's free cash flow losses and cautious future projections weigh on its outlook, suggesting limited upside for value-focused investors.

Latest articles

NextNRG shares double as buying spikes, but the numbers show a catch

NextNRG shares double as buying spikes, but the numbers show a catch

19 May 2026
NextNRG shares more than doubled Tuesday, closing at $0.8288 and rising to about $0.91 after hours, after reporting April revenue up 56% to $9.4 million, its highest on record. Gross margin for April reached 8.3%. Trading volume topped 344 million shares, with market value near $135 million. The company posted a first-quarter net loss of $10.8 million and had $208,048 in cash at March 31.
AST SpaceMobile Shares Whipsaw in Volatile Trading

AST SpaceMobile Shares Whipsaw in Volatile Trading

19 May 2026
AST SpaceMobile shares closed up 2.2% at $88.75 Tuesday after volatile trading between $78.68 and $90.88. Investors shifted focus from last week’s earnings miss to the company’s plan to launch 45 BlueBird satellites this year, with two already en route to Cape Canaveral. First-quarter revenue rose to $14.7 million, but net loss widened to $191 million. AST reported $3.46 billion in cash at quarter’s end.
Warby Parker Shares Slip After AI Glasses Reveal; Investors React

Warby Parker Shares Slip After AI Glasses Reveal; Investors React

19 May 2026
Warby Parker shares fell Tuesday after the company unveiled its first “Intelligent Eyewear” with Google and Samsung, but did not disclose pricing or a launch date. The stock traded at $25.51, with volume triple the average. The new AI-powered glasses are set for a fall launch and will support multiple prescriptions and lens options. First-quarter revenue rose 8.3% to $242.4 million, while gross margin slipped to 54%.
Go toTop